APA

Potkul R. K., Unger J. M., Livingston R. B., Crew K. D., Wilczynski S. P., Salomon C. G., Smith B. L., Wong L., Campbell D. L., Einspahr D. E., Anderson G. L., Hershman D., Goodman G. E., Brown P. H., Meyskens F. L. & Albain K. S. (2016). Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. : NPJ breast cancer.

Chicago

Potkul Ronald K, Unger Joseph M, Livingston Robert B, Crew Katherine D, Wilczynski Sharon P, Salomon Caryl G, Smith Barbara L, Wong Lucas, Campbell David L, Einspahr David E, Anderson Garnet L, Hershman Dawn, Goodman Gary E, Brown Powel H, Meyskens Frank L and Albain Kathy S. 2016. Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. : NPJ breast cancer.

Harvard

Potkul R. K., Unger J. M., Livingston R. B., Crew K. D., Wilczynski S. P., Salomon C. G., Smith B. L., Wong L., Campbell D. L., Einspahr D. E., Anderson G. L., Hershman D., Goodman G. E., Brown P. H., Meyskens F. L. and Albain K. S. (2016). Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. : NPJ breast cancer.

MLA

Potkul Ronald K, Unger Joseph M, Livingston Robert B, Crew Katherine D, Wilczynski Sharon P, Salomon Caryl G, Smith Barbara L, Wong Lucas, Campbell David L, Einspahr David E, Anderson Garnet L, Hershman Dawn, Goodman Gary E, Brown Powel H, Meyskens Frank L and Albain Kathy S. Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. : NPJ breast cancer. 2016.